LDN193189(DM 3189) is a selective BMP signaling inhibitor, inhibits the transcriptional activity of the BMP type I receptors ALK2 and ALK3 with IC50 of 5 nM and 30 nM, respectively, exhibits 200-fold selectivity for BMP versus TGF-
For research use only. We do not sell to patients.
Chemical Information
Name LDN193189
Iupac Chemical Name 4-[6-(4-Piperazin-1-yl-phenyl)-pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline
Synonyms LDN193189;LDN 193189;LDN-193189
Molecular Formula C25H22N6
Molecular Weight 406.48
Smile N1(CCNCC1)C1=CC=C(C=C1)C=1C=NC=2N(C1)N=CC2C2=CC=NC1=CC=CC=C21
InChiKey CDOVNWNANFFLFJ-UHFFFAOYSA-N
InChi InChI=1S/C25H22N6/c1-2-4-24-22(3-1)21(9-10-27-24)23-16-29-31-17-19(15-28-25(23)31)18-5-7-20(8-6-18)30-13-11-26-12-14-30/h1-10,15-17,26H,11-14H2
CAS Number 1062368-24-4
Related CAS
Ordering Information
Packaging Price Availability Purity Shipping Time
Bulk Enquiry Enquiry Enquiry
Formulation off-white solid
Purity 98%
Storage -20 ºC for 3 years
Solubility DMSO ��4mg/mL; Water ��30mg/mL; Ethanol <1mg/mL
Handling
Shipping Condition Shipped under ambient temperature
HS Code
Targets
Mechanism
Cell study
Animal study
Clinical study